Bristol-Myers Squibb
About
Bristol-Myers Squibb is a global biopharmaceutical company whose mission is to discover, develop and deliver innovative medicines that help patients prevail over serious diseases. It is one of the large multinational drug makers, and its Cambridge site places it within the Boston area’s concentration of life sciences companies. The company’s main research areas include cancer, blood disorders, immune diseases, cardiovascular disease and neuroscience.
The company took its current form in 1989 through the merger of Bristol-Myers and Squibb, two long-established American drug makers, and in 2019 it acquired Celgene, adding major hematology and cell therapy programs. It develops both small-molecule drugs and biologics, including immuno-oncology medicines that help the immune system fight cancer. Its shares are publicly traded on the New York Stock Exchange.
What to Know
- The company belongs to the Cambridge, Greater Boston and Somerville chambers of commerce.
- It is headquartered outside Massachusetts and operates research sites around the world.
- Its best-known products include the cancer immunotherapy Opdivo.
Is this your business?
Claim it to add hours, photos, a description and a spotlight story.